Outlook Therapeutics, Inc. (OTLK) Insider Trading
1 insider purchase in the last 7 days
| INSIDER | DATE | SHARES | PRICE | TOTAL VALUE | OWNED AFTER | Δ OWNED | FILING |
|---|---|---|---|---|---|---|---|
| Sukhtian Faisal Ghiath Director | Jul 29, 2026 | 95,398 | $1.05 | $100K | 220,972 | +76.0% |
Want more?
Sign up free to see 30+ days of history, set alerts, and track OTLK on your watchlist.
Start for FreeAbout Outlook Therapeutics, Inc. Insider Trading
1 insider at Outlook Therapeutics, Inc. (OTLK) has purchased stock in the past 90 days, totaling $100K across 1 transaction (95,398 shares).
The most recent purchase was by Director Sukhtian Faisal Ghiath on July 29, 2026 — a $100K buy of 95,398 shares at $1.05, bringing their total holdings to 220,972 shares.
Track OTLK insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.